-
Under the general trend of innovation in the pharmaceutical industry, the approval of domestically produced innovative drugs is showing a blowout trend
Time of Update: 2021-11-04
According to data, the approval of domestically-made innovative drugs for the market this year is showing a blowout trend .
According to the current trend, the industry believes that in the next 2-3 years, there will be more than 20 PD-1 products on the global market, while 15 PD-1 products on the domestic market will become increasingly fierce .
-
Preview of the third quarterly report of the API industry
Time of Update: 2021-10-20
Regarding the reasons for the changes in performance, Huahai Pharmaceutical said that during the reporting period, the company’s net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses fell sharply year-on-year, mainly due to the general decline in raw material drug product prices, the decline in the US dollar exchange rate, and product sales.
-
Takeda and Poseida reached a $3.6 billion agreement with non-viral gene therapy
Time of Update: 2021-10-20
Poseida Therapeutics Announces Research Collaboration with Takeda for Novel Non-Viral In Vivo Gene Therapies 3.
Poseida Therapeutics Announces Research Collaboration with Takeda for Novel Non-Viral In Vivo Gene Therapies 3.
-
The "2020-2021 Chinese Family Standing Medicine Listed Brands" campaign is underway
Time of Update: 2021-10-11
Shanghai, September 22, 2021/PRNewswire/ - Starting in June of this year, in order to enhance the brand power of outstanding pharmaceutical companies and products, we will provide every Chinese family with a scientific and practical family-prepared medicine guide, "2020 -In 2021, China's household standing medicines will be listed on the "Brands" campaign, which is currently under application .
-
Congratulations to Aiweite for obtaining the exclusive agent of Xi'an Libang injection grade oleic acid and sodium oleate
Time of Update: 2021-07-29
, using Shanghai Aiweite's extensive customer relationships and good reputation in the field of fat emulsion research and development and production to carry out the global promotion of sodium oleate oleate And sales operations .
Shanghai Aiweite Pharmaceutical Technology Co.
-
More than 70 rare disease drugs have been listed in China
Time of Update: 2021-06-28
During the interview, the reporter learned that with the approval of related treatment drugs in China, long-term treatment of patients with urea cycle disorders and the improvement of their quality of life have new guarantees .
-
Eli Lilly’s business model adjustment for multinational pharmaceutical companies has a large number of drugs "patent cliff" here
Time of Update: 2021-04-27
The CCO mixed line team is cancelled, what will happen to the patent expired drugs?In addition, in the email, Eli Lilly also stated, “During the business transformation and adjustment at the end of last year, based on the uncertain factors of the three products (Xinbaida, Cialy, and Futai), in order to smooth the business transition and explore uncertainties.
-
Personnel changes of epoxy resin industry association
Time of Update: 2021-03-30
[China Epoxy Network (China Epoxy Industry Online) October 24, 2011: The China Epoxy Industry Association recently announced that in order to further strengthen the work of the association, the chair
-
Pre-loss of more than 2.2 billion yuan! People's fu medicine 3 billion goodwill "thunderstorm" landed at once
Time of Update: 2021-03-04
fu medicine has recently attracted market attention. First at the end of 2018 Fentanne "black swan" event, and then in January this year, the company's earnings forecast showed a sharp decline, the s
-
Asda Paint provides educational support to poor girls in India
Time of Update: 2021-03-03
China Coatings Network : Astra Coatings Systems (NYSE: AXTA) has teamed up with the Pardada Pardadi Education Association (PPES) to provide educational support to poor girls in India.
-
The third supplement to the 2010 edition of the Chinese Pharmacopoeia will be promulgated in the nearth
Time of Update: 2021-02-04
The 2010 edition of the Chinese Pharmacopeia, on the basis of maintaining a forward-looking, scientific and normative basis, focuses on solving outstanding problems that restrict the quality and safety of drugs, strives to improve the quality control level of drug standards, and objectively reflects the current level of pharmaceutical industry, clinical drug use and testing technology in China.
-
It's going to take 3.5 billion image agent varieties
Time of Update: 2021-01-07
Iodine kesal injections to be approved enterprise source: Mi net one-click retrieval of minenet data show that Harbin Triple Pharmaceuticals according to imitation 6 categories of submitted iodized keshaol injection application in the review and approval; source: MiNet Database, NMPA
-
What about the pharmaceutical sector? Five factors will support the business climate
Time of Update: 2020-11-18
At present, many provinces in China are actively promoting the share of domestic large-scale medical equipment in medical institutions, is expected to accelerate domestic replacement, promote domestic IVD product innovation, drive the rapid development of the market, the market size is expected to exceed 760 billion yuan in 2020.
-
In the age of innovation, domestic pharmaceutical companies prefer this track
Time of Update: 2020-11-15
Specifically, in 2020, Kadcyla, the country's first ADC drug, was approved; From the proportion of domestic new drugs has been close to 50%, and the growth rate is still continuing in the background, China's pharmaceutical enterprises have a considerable strength of new drug innovation, in the domestic market has gradually been able to compete with foreign investment, the future or will achieve beyond.
-
The export situation of API is depressed Industrial transformation and upgrading pressure is great
Time of Update: 2020-08-02
veS Xinhua data in January and February show that China's API exports continued to be depressed since the fourth quarter of 2012, short-term difficult to reverse.
